| Enzo |
ALX-270-033-M050 |
AMT . hydrochloride
|
50mg |
|
|
| Enzo |
ALX-270-033-M010 |
AMT . hydrochloride
|
10mg |
|
|
| Enzo |
ALX-270-034-M010 |
ODQ
|
10mg |
|
|
| Enzo |
ALX-270-034-M050 |
ODQ
|
50mg |
|
|
| Enzo |
ALX-270-029-M050 |
S-(3-Aminopropyl)-ITU . dihydrobromide
|
50mg |
|
|
| Enzo |
ALX-270-029-M010 |
S-(3-Aminopropyl)-ITU . dihydrobromide
|
10mg |
|
|
| Enzo |
ALX-270-028-M050 |
S-Isopropyl-ITU . hydrobromide
|
50mg |
|
|
| Enzo |
ALX-270-028-M010 |
S-Isopropyl-ITU . hydrobromide
|
10mg |
|
|
| Enzo |
ALX-270-024-M010 |
1,4-PB-ITU . dihydrobromide
|
10mg |
|
|
| Enzo |
ALX-270-025-M250 |
S-Ethyl-ITU . hydrobromide
|
250mg |
|
|
| Enzo |
ALX-270-026-M010 |
1,3-PB-ITU . dihydrobromide
|
10mg |
|
|
| Enzo |
ALX-270-027-M250 |
S-Methyl-ITU . sulfate
|
250mg |
|
|
| Enzo |
ALX-270-024-M050 |
1,4-PB-ITU . dihydrobromide
|
50mg |
|
|
| Enzo |
ALX-270-023-M010 |
alpha-Guanidinoglutaric acid
|
10mg |
|
|
| Enzo |
ALX-270-022-M050 |
AEBSF . hydrochloride
|
50mg |
|
|
| Enzo |
ALX-270-022-G001 |
AEBSF . hydrochloride
|
1g |
|
|
| Enzo |
ALX-270-022-M250 |
AEBSF . hydrochloride
|
250mg |
|
|
| Enzo |
ALX-270-015-M005 |
Leuhistin
|
5mg |
|
|
| Enzo |
ALX-270-012-M005 |
Arphamenine B
|
5mg |
|
|
| Enzo |
ALX-270-013-M001 |
Ebelactone A
|
1mg |
|
|
| Enzo |
ALX-270-015-M001 |
Leuhistin
|
1mg |
|
|
| Enzo |
ALX-270-010-M050 |
L-NIL . dihydrochloride
|
50mg |
|
|
| Enzo |
ALX-270-010-M010 |
L-NIL . dihydrochloride
|
10mg |
|
|
| Enzo |
ALX-270-009-M005 |
3-Bromo-7-nitroindazole
|
5mg |
|
|
| Enzo |
ALX-270-004-M100 |
7-Nitroindazole
|
100mg |
|
|
| Enzo |
ALX-270-005-G001 |
2,4-Diamino-6-hydroxypyrimidine
|
1g |
|
|
| Enzo |
ALX-270-008-M025 |
(2S)-(+)-Amino-6-iodoacetamidohexanoic acid
|
25mg |
|
|
| Enzo |
ALX-270-009-M050 |
3-Bromo-7-nitroindazole
|
50mg |
|
|
| Enzo |
ALX-270-008-M005 |
(2S)-(+)-Amino-6-iodoacetamidohexanoic acid
|
5mg |
|
|
| Enzo |
ALX-260-166-M001 |
Z-VRPR-FMK
|
1mg |
|
|
| Enzo |
ALX-260-166-MC05 |
Z-VRPR-FMK
|
0.5mg |
|
|
| Enzo |
ALX-260-165-M001 |
MMP-3 inhibitor
|
1mg |
|
|
| Enzo |
ALX-260-165-M005 |
MMP-3 inhibitor
|
5mg |
|
|
| Enzo |
ALX-260-160-M005 |
Ac-LDESD-CHO
|
5mg |
|
|
| Enzo |
ALX-260-160-M001 |
Ac-LDESD-CHO
|
1mg |
|
|
| Enzo |
ALX-260-159-M003 |
Q-VD-OPH
|
3mg |
|
|
| Enzo |
ALX-260-158-M005 |
Ac-AEVD-CHO
|
5mg |
|
|
| Enzo |
ALX-260-158-M001 |
Ac-AEVD-CHO
|
1mg |
|
|
| Enzo |
ALX-260-155-M001 |
PKC zeta pseudosubstrate (myristoylated)
|
1mg |
|
|
| Enzo |
ALX-260-153-R020 |
Z-AAD-CMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-154-R100 |
Z-YVAD-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-154-R020 |
Z-YVAD-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-144-R020 |
Z-IETD-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-144-R100 |
Z-IETD-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-145-R020 |
Z-LEHD-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-148-R100 |
Z-FA-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-148-R020 |
Z-FA-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-145-R100 |
Z-LEHD-FMK (Ready-to-Use)
|
100µl |
|
|
| Enzo |
ALX-260-142-R020 |
Z-LEVD-FMK (Ready-to-Use)
|
20µl |
|
|
| Enzo |
ALX-260-143-R100 |
Z-VEID-FMK (Ready-to-Use)
|
100µl |
|
|